title: Structure-Function-Based Quantitative Brain Image Analysis.
abstract: Many neurodegenerative dementias produce significant alterations in the brain that are often not detectable by neurologic tests or with structural imaging. PET is ideally suited for monitoring cell/molecular events early in the course of a disease as well as during pharmacologic therapy. During the past 2 decades, molecular neuroimaging using PET and magnetic resonance (MR) has advanced elegantly and steadily gained importance in the clinical and research arenas. Software- and hardware-based multimodality brain imaging allowing the correlation between anatomic and molecular information has revolutionized clinical diagnosis and now offers unique capabilities for the clinical neuroimaging community and neuroscience researchers at large.
authors.affiliation: Division of Nuclear Medicine, Geneva University Hospital, Geneva CH-1211, Switzerland; Geneva Neuroscience Center, Geneva University, Geneva CH-1211, Switzerland. Electronic address: habib.zaidi@hcuge.ch.
authors.forename: Habib
authors.initials: H
authors.lastname: Zaidi
authors.affiliation: Division of Nuclear Medicine, Geneva University Hospital, Geneva CH-1211, Switzerland.
authors.forename: Marie-Louise
authors.initials: ML
authors.lastname: Montandon
authors.affiliation: Neurology, Department of Clinical Neurosciences, Geneva University Hospital, Geneva CH-1211, Switzerland.
authors.forename: Frédéric
authors.initials: F
authors.lastname: Assal
keywords: Image fusion; MRI; Molecular brain imaging; Neurodegenerative disease; PET; PET-MRI; Quantification; Structural brain imaging